童平, 侯新朴, 邵森, 张颖妹, 张晨晖. 无环鸟苷亲脂性前体药物脂质体的制备及体外抗病毒活性(英文)J. 药学学报, 1992, 27(1): 15-21.
引用本文: 童平, 侯新朴, 邵森, 张颖妹, 张晨晖. 无环鸟苷亲脂性前体药物脂质体的制备及体外抗病毒活性(英文)J. 药学学报, 1992, 27(1): 15-21.
P Tong, XP Hou, S Shao, YM Zhang, CH Zhang. PREPARTION AND IN VITRO ANTIVIRAL ACTIVITY OF LIPOSOMES OF LIPOPHILIC ESTERS OF ACYCLOVIRJ. Acta Pharmaceutica Sinica, 1992, 27(1): 15-21.
Citation: P Tong, XP Hou, S Shao, YM Zhang, CH Zhang. PREPARTION AND IN VITRO ANTIVIRAL ACTIVITY OF LIPOSOMES OF LIPOPHILIC ESTERS OF ACYCLOVIRJ. Acta Pharmaceutica Sinica, 1992, 27(1): 15-21.

无环鸟苷亲脂性前体药物脂质体的制备及体外抗病毒活性(英文)

PREPARTION AND IN VITRO ANTIVIRAL ACTIVITY OF LIPOSOMES OF LIPOPHILIC ESTERS OF ACYCLOVIR

  • 摘要: 本文通过将无环鸟苷(acyclovir,简称ACV)2’位羟基分别与月桂酰氯或棕榈酰氯进行酯化反应,制得亲脂性前体药物无环鸟苷月桂酸酯和无环鸟苷棕榈酸酯(分别简称为C12-ACV和C16-ACV),使脂质体包封率从ACV的29.9%提高到C12-ACV的95.6%和C16-ACV的97.1%;漏泄实验表明在4℃透析60h后,一半以上的ACV从脂质体中漏泄,而C12-ACV和C16-ACV的滞留率分别为70%和80%;体外抗疱疹病毒的试验中,在最低试验浓度0.044μmol/L时,ACV不显示抗病毒活性,而C16-ACV脂质体抑制细胞病变率达75%,说明前体药物通过与脂质体脂膜的结合增加了药物的进入细胞能力,从而提高了ACV的抗病毒能力。

     

    Abstract: The long chain acyclovir such as the acyclovir laurate and acyclovirpalmitate were prepared directly from acyclovir by application of the usual esterification meth-ods with appropriate acyl chlorides. The lipophilic prodrugs were found to be retained easier byliposomes whereas acyclovir escaped readily from liposomes.When assayed in African green mon-key cell cultures against herpes simplex virus type I strain, the acyclovir palmitate liposomesproved to be more active compared with the parent drug and its liposome, suggesting an en-hanced compatibility between the ester and liposomal lipids and an increased uptake ofencapsulated prodrug by infected cells.

     

/

返回文章
返回